Skip to main content

RT @synovialjoints: Plenary: Real-world observational study >1500 pts with IA, 1 year retention infliximab biosimilar

Nov 13, 2022 2:31 pm
Social Author Name
Dr. Antoni Chan
Tweet Content
Plenary: Real-world observational study >1500 pts with IA, 1 year retention infliximab biosimilar CT-P13 to GP1111 switch was high. Retention was higher in originator-experienced (92vs83%) & low disease activity Nabi H, DANBIO Abs1112 https://t.co/z84AMUS3GK #ACR22 @RheumNow https://t.co/SgGhd33Esl
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×